Student "Pool Party" Protests Merck
Global Health Groups Urge Big Pharma To Give Poor Countries Discounts
A group of Harvard global health activists staged a protest Friday in front of Merck’s laboratory near the Harvard Medical School to urge the drug company to provide discounted HIV and AIDS medicine to poor countries.
The protest was billed as a “pool party demonstration”—replete with beach balls, an inflatable pool, and students in swim trunks—to demand that Merck “jump into the pool,” a reference to the Medicine Patent Pool.
The Medicine Patent Pool is an organization that negotiates deals with drug companies to ensure the availability in low-income and middle-income countries of discounted medicine to fight the human immunodeficiency virus. In many of these countries, drugs to fight the disease are far too expensive to be affordable to ordinary individuals. The deals struck by the Medicine Patent Pool seek to reduce costs while also attempting to ensure that the companies are minimally impacted by the discounts.
Merck Research Laboratories develops drugs to help treat HIV, but has not joined the patent pool. Merck does provide discounts for low-income countries but has not extended them to middle-income countries, which was a focus of Friday’s protest. The protest was organized by the Harvard College Global Health and AIDS Coalition and Students for Global Health and Justice at the Harvard Medical School.
According to Alyssa T. Yamamoto ’12, a member of the Harvard College group, demonstrators are demanding that Merck “join the pool by January 2012 or at the least implement a similar program” by that deadline.
Yamamoto said that the pool party was inspired by similar protests against Johnson & Johnson in the United Kingdom, led by the Stop AIDS Campaign.
At Friday’s protests, the student speakers at the event addressed the audience while standing in the inflatable pool, criticizing Merck’s refusal to join the pool as a human rights violation.
Gilead, a competitor to Merck, has already signed an agreement with the Pool, according to Matthew F. Basilico ’08, a second year student at Harvard Medical School. At least four other peer companies are in negotiations to join the pool.
Basilico noted that a further goal of the demonstration was to have Merck create an “agreement with the pool to include pro-access provisions, for middle-income countries and active pharmaceutical ingredients,” referring to the need to make the drugs not just affordable but also easily available.
Nworah B. Ayogu ’10, a second year medical student and president of the Medical School’s Student Council, noted afterwards that the demonstrators were content with how the event went. He said that he hoped that Merck would now “realize how seriously Harvard takes its commitment to the underserved and the Medical school takes its mission to alleviate human suffering caused by disease.”